Autres langues NanoVibronix, Inc.

Actions

NAOV

US63008J6038

Temps Différé Nasdaq Autres places de cotation 17:00:08 07/05/2024			Varia. 5j.	Varia. 1 janv.
0,7516 ^USD	+1,71%		+2,26%	-34,64%

01/05	NanoVibronix annonce que PainShield sera inclus dans le contrat FSS du Département des Anciens Combattants ? FSS du Département des Anciens Combattants	CI
08/04	NanoVibronix, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award	01/05
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award	01/05
NanoVibronix : Failure to Satisfy Listing Rule - Form 8-K	15/04
NanoVibronix Issues Letter to Stockholders	09/04
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield	28/03
NanoVibronix Featured in Your Bladder Health Magazine	06/12
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	04/12
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	04/12
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan	28/11
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan	28/11
NanoVibronix Regains Nasdaq Compliance	21/11
NanoVibronix Issues Letter to Shareholders	14/11
NanoVibronix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1	07/11
Investors Eye Fed Moves as US Futures Trend Lower in Friday's Premarket	20/10/23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff	28/09/23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff	27/09/23
NanoVibronix, Inc. Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff	27/09/23
NanoVibronix Files Registration Statement on Behalf of Selling Shareholders	13/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues NanoVibronix, Inc.

Actions

NAOV

US63008J6038

Autres langues

Filtres